These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2280013)

  • 1. Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.
    Zabransky RJ; Bayola-Mueller L; Jenkins SG; Pitkin DR; Schreckenberger PC; Celig DM; Spiegel CA
    J Clin Microbiol; 1990 Dec; 28(12):2804-5. PubMed ID: 2280013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
    Zabransky RJ; Bobey DG; Barry AL; Allen SD; Fuchs PC; Gerlach EH; Thornsberry C; Sheikh W; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):190-1. PubMed ID: 2643621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Apr; 26(4):776-7. PubMed ID: 2896669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.
    Sutter VL; Emmerman J; Randall E; Zabransky RJ; Birk RJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):424-6. PubMed ID: 3888103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sensititre broth microdilution and agar dilution susceptibility testing techniques for meropenem to determine accuracy, reproducibility, and predictive values.
    Dowzicky MJ; Nadler HL; Sheikh W
    J Clin Microbiol; 1994 Sep; 32(9):2204-7. PubMed ID: 7814547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.
    Mangels JI; Lindberg LH
    J Clin Microbiol; 1985 Feb; 21(2):269-72. PubMed ID: 3972999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eubacterium lentum ATCC 43055, a new reference strain for quality control of anaerobic susceptibility tests.
    Barry AL; Zabransky RJ
    J Clin Microbiol; 1990 Oct; 28(10):2375-6. PubMed ID: 2229368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to meropenem.
    Nord CE; Lindmark A; Persson I
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.
    Kronvall G; Holst E
    Clin Microbiol Infect; 2000 Apr; 6(4):195-201. PubMed ID: 11168107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
    Sheikh W; Pitkin DH; Nadler H
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S361-6. PubMed ID: 8324148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
    Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
    Pitkin DH; Sheikh W; Nadler H
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():251-8. PubMed ID: 2808211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN; Barry AL; Fuchs PC; Allen SD
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.
    Aldridge KE; Morice N; Schiro DD
    Antimicrob Agents Chemother; 1994 Apr; 38(4):889-93. PubMed ID: 8031067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.
    Bale MJ; Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1994 May; 19(1):65-8. PubMed ID: 7956017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of SM-7338, a new carbapenem in mediums recommended for the susceptibility testing of anaerobic bacteria and gonococci.
    Jones RN; Gardiner RV
    Diagn Microbiol Infect Dis; 1989; 12(3):271-3. PubMed ID: 2507217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.